Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907725 · ClinicalTrials.gov registry record · NA
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
A NA study, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
NCT00907725 is a NA study that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 376 participants.
The verdict
NCT00907725, a NA study, has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women randomized to ultrasonographic determination of completion of medical abortion will have MORE follow-up visits/interventions beyond standard protocol than those randomized to medical abortion follow-up with serum BhCG. The investigators also hope to explore satisfaction with BhCG based follow-up among women seeking medical abortion. Investigators hypothesize that the majority of women who choose to follow-up with serum BhCG will be satisfied with this method of medical abortion follow-up.
Interventions
- OTHER serum BhCG follow-up
- OTHER ultrasonographic follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907725
The ClinicalTrials.gov registry entry for NCT00907725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which serum BhCG follow-up is the first listed.
NCT00907725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907725 about?
NCT00907725 is a clinical study titled "Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?". The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women randomized to ultrasonographic determination of completion of medical abortion will have MORE follow-up visits/inter...
What is the current status of trial NCT00907725?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2009-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00907725?
The interventions under investigation include: serum BhCG follow-up (OTHER), ultrasonographic follow-up (OTHER).
Who is sponsoring clinical trial NCT00907725?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.